Literature DB >> 11264988

Mouse models of atherosclerosis.

C A Reardon1, G S Getz.   

Abstract

Atherosclerosis bears many features of a chronic inflammation that affects the intima of large and medium-sized arteries. In recent years apolipoprotein E-deficient and LDL receptor-deficient mice have been used to examine the effects of various gene products on the development of atherosclerosis. In the present review the effects of genetics, apolipoprotein E, inflammatory gene modifiers, lipoprotein modifications, lipoprotein receptors, vessel wall expression of lipoprotein-metabolizing enzymes, and the atheroprotective role of HDL on atherosclerosis in these mice are discussed. The importance of examining lesions that are more advanced than fatty streaks and careful histologic and immunologic examination of lesion composition is emphasized.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11264988     DOI: 10.1097/00041433-200104000-00010

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  22 in total

1.  Blockade of platelet-derived growth factor or its receptors transiently delays but does not prevent fibrous cap formation in ApoE null mice.

Authors:  Koichi Kozaki; Wolfgang E Kaminski; Jingjing Tang; Stan Hollenbach; Per Lindahl; Carol Sullivan; Jin-Chen Yu; Keith Abe; Paul J Martin; Russell Ross; Christer Betsholtz; Neill A Giese; Elaine W Raines
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

2.  Replacing vascular corrosion casting by in vivo micro-CT imaging for building 3D cardiovascular models in mice.

Authors:  Bert Vandeghinste; Bram Trachet; Marjolijn Renard; Christophe Casteleyn; Steven Staelens; Bart Loeys; Patrick Segers; Stefaan Vandenberghe
Journal:  Mol Imaging Biol       Date:  2011-02       Impact factor: 3.488

3.  Responsiveness of cardiometabolic-related microbiota to diet is influenced by host genetics.

Authors:  Annalouise O'Connor; Pamela M Quizon; Jody E Albright; Fred T Lin; Brian J Bennett
Journal:  Mamm Genome       Date:  2014-08-27       Impact factor: 2.957

Review 4.  Biomarkers and sustainable innovation in cardiovascular drug development: lessons from near and far afield.

Authors:  Russell M Medford; T Forcht Dagi; Robert S Rosenson; Margaret K Offermann
Journal:  Curr Atheroscler Rep       Date:  2013-05       Impact factor: 5.113

5.  VLDL best predicts aortic root atherosclerosis in LDL receptor deficient mice.

Authors:  Paul A VanderLaan; Catherine A Reardon; Ronald A Thisted; Godfrey S Getz
Journal:  J Lipid Res       Date:  2008-10-28       Impact factor: 5.922

6.  Influence of PDZK1 on lipoprotein metabolism and atherosclerosis.

Authors:  Olivier Kocher; Ayce Yesilaltay; Ching-Hung Shen; Songwen Zhang; Kathleen Daniels; Rinku Pal; Jianzhu Chen; Monty Krieger
Journal:  Biochim Biophys Acta       Date:  2008-03-10

Review 7.  Mediators of inflammation in polycystic ovary syndrome in relation to adiposity.

Authors:  Thozhukat Sathyapalan; Stephen L Atkin
Journal:  Mediators Inflamm       Date:  2010-04-08       Impact factor: 4.711

8.  Dietary cholesterol worsens adipose tissue macrophage accumulation and atherosclerosis in obese LDL receptor-deficient mice.

Authors:  Savitha Subramanian; Chang Yeop Han; Tsuyoshi Chiba; Timothy S McMillen; Shari A Wang; Antonio Haw; Elizabeth A Kirk; Kevin D O'Brien; Alan Chait
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-01-31       Impact factor: 8.311

9.  Molecular mechanisms of obesity and diabetes: at the intersection of weight regulation, inflammation, and glucose homeostasis.

Authors:  Robert W O'Rourke
Journal:  World J Surg       Date:  2009-10       Impact factor: 3.352

10.  Loss of PDZK1 causes coronary artery occlusion and myocardial infarction in Paigen diet-fed apolipoprotein E deficient mice.

Authors:  Ayce Yesilaltay; Kathleen Daniels; Rinku Pal; Monty Krieger; Olivier Kocher
Journal:  PLoS One       Date:  2009-12-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.